globotriaosyl-lysosphingolipid has been researched along with Heart-Diseases* in 1 studies
1 other study(ies) available for globotriaosyl-lysosphingolipid and Heart-Diseases
| Article | Year |
|---|---|
Biomarkers associated with clinical manifestations in Fabry disease patients with a late-onset cardiac variant mutation.
Urine and plasma biomarkers were analyzed using tandem mass spectrometry. A large cohort of 191 adult and pediatric Fabry patients carrying the IVS4+919G>A mutation was studied. Some patients were members of the same family.. It might thus be of particular interest to monitor children with high levels of these biomarkers, as part of a longitudinal study in order to determine if the excretion profile at a young age is predictive of the outcomes of disease severity in adulthood. Topics: Adult; Age Factors; Biomarkers; Child; Fabry Disease; Female; Glycolipids; Heart Diseases; Humans; Late Onset Disorders; Male; Mutation; Severity of Illness Index; Sex Factors; Sphingolipids; Taiwan | 2017 |